Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hepatitis: a rare, but important, complication of infliximab therapy for psoriasis.

Literature DB >> 16681606

Hepatitis: a rare, but important, complication of infliximab therapy for psoriasis.

S Wahie, A Alexandroff, N J Reynolds.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2006 PMID： 16681606 DOI： 10.1111/j.1365-2230.2006.02086.x

Source DB: PubMed Journal: Clin Exp Dermatol ISSN： 0307-6938 Impact factor: 3.470

Keyword Cloud
Cited

× No keyword cloud information.

11 in total

1. A practical approach to monitoring patients on biological agents for the treatment of psoriasis.

Authors: Jason J Emer; Amylynne Frankel; Joshua A Zeichner
Journal: J Clin Aesthet Dermatol Date: 2010-08

Review 2. Infliximab-related hepatitis: a case study and literature review.

Authors: Francisco Colina; Aída Molero; Begoña Casís; Pilar Martínez-Montiel
Journal: Dig Dis Sci Date: 2013-05-05 Impact factor: 3.199

3. Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 cases.

Authors: Susana Rodrigues; Susana Lopes; Fernando Magro; Hélder Cardoso; Ana Maria Horta e Vale; Margarida Marques; Eva Mariz; Miguel Bernardes; Joanne Lopes; Fátima Carneiro; Guilherme Macedo
Journal: World J Gastroenterol Date: 2015-06-28 Impact factor: 5.742

Review 4. Anti-tumour necrosis factor agent and liver injury: literature review, recommendations for management.

Authors: Roberta Elisa Rossi; Ioanna Parisi; Edward John Despott; Andrew Kenneth Burroughs; James O'Beirne; Dario Conte; Mark Ian Hamilton; Charles Daniel Murray
Journal: World J Gastroenterol Date: 2014-12-14 Impact factor: 5.742

Review 5. Liver injury from tumor necrosis factor-α antagonists: analysis of thirty-four cases.

Authors: Marwan Ghabril; Herbert L Bonkovsky; Clarissa Kum; Tim Davern; Paul H Hayashi; David E Kleiner; Jose Serrano; Jim Rochon; Robert J Fontana; Maurizio Bonacini
Journal: Clin Gastroenterol Hepatol Date: 2013-01-17 Impact factor: 11.382

6. Toxic hepatitis induced by infliximab in a patient with rheumatoid arthritis with no relapse after switching to etanercept.

Authors: K M Carlsen; L Riis; O R Madsen
Journal: Clin Rheumatol Date: 2009-04-16 Impact factor: 2.980

Hepatitis: a rare, but important, complication of infliximab therapy for psoriasis.

1. A practical approach to monitoring patients on biological agents for the treatment of psoriasis.

Review 2. Infliximab-related hepatitis: a case study and literature review.

3. Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 cases.

Review 4. Anti-tumour necrosis factor agent and liver injury: literature review, recommendations for management.

Review 5. Liver injury from tumor necrosis factor-α antagonists: analysis of thirty-four cases.

6. Toxic hepatitis induced by infliximab in a patient with rheumatoid arthritis with no relapse after switching to etanercept.

7. Safety and efficacy of anti-tumor necrosis factors α in patients with psoriasis and chronic hepatitis C.

Review 8. Tumor necrosis factor-α inhibitors and chronic hepatitis C: a comprehensive literature review.

Review 9. Infliximab-related hepatitis: discussion of a case and review of the literature.

10. Infliximab for the treatment of plaque psoriasis.